83 related articles for article (PubMed ID: 17030970)
1. Angiotensin-converting enzyme inhibition reduces lipid deposits in myocardium and improves left ventricular function of obese zucker rats.
Toblli JE; Cao G; Rivas C; DeRosa G; Domecq P
Obesity (Silver Spring); 2006 Sep; 14(9):1586-95. PubMed ID: 17030970
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular protective role of a low-dose antihypertensive combination in obese Zucker rats.
Toblli JE; DeRosa G; Rivas C; Cao G; Piorno P; Pagano P; Forcada P
J Hypertens; 2003 Mar; 21(3):611-20. PubMed ID: 12640256
[TBL] [Abstract][Full Text] [Related]
3. ACE inhibition and AT1 receptor blockade prevent fatty liver and fibrosis in obese Zucker rats.
Toblli JE; Muñoz MC; Cao G; Mella J; Pereyra L; Mastai R
Obesity (Silver Spring); 2008 Apr; 16(4):770-6. PubMed ID: 18239590
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme inhibition and angiogenesis in myocardium of obese Zucker rats.
Toblli JE; Cao G; DeRosa G; Di Gennaro F; Forcada P
Am J Hypertens; 2004 Feb; 17(2):172-80. PubMed ID: 14751661
[TBL] [Abstract][Full Text] [Related]
5. Enalapril prevents fatty liver in nephrotic rats.
Toblli JE; Ferder L; Stella I; Angerosa M; Inserra F
J Nephrol; 2002; 15(4):358-67. PubMed ID: 12243364
[TBL] [Abstract][Full Text] [Related]
6. ACE inhibitor and angiotensin type I receptor antagonist in combination reduce renal damage in obese Zucker rats.
Toblli JE; DeRosa G; Cao G; Piorno P; Pagano P
Kidney Int; 2004 Jun; 65(6):2343-59. PubMed ID: 15149348
[TBL] [Abstract][Full Text] [Related]
7. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
Blanco S; Vaquero M; Gómez-Guerrero C; López D; Egido J; Romero R
Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368
[TBL] [Abstract][Full Text] [Related]
8. Vasopeptidase inhibition prevents target organ damage and improves survival in spontaneously hypertensive rats.
Linz W; Schäfer S; Afkham F; Gerl M; Schmidts HL; Rütten H
J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):155-61. PubMed ID: 17094052
[TBL] [Abstract][Full Text] [Related]
9. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
Kompa AR; See F; Lewis DA; Adrahtas A; Cantwell DM; Wang BH; Krum H
J Pharmacol Exp Ther; 2008 Jun; 325(3):741-50. PubMed ID: 18334667
[TBL] [Abstract][Full Text] [Related]
10. Significance of exaggerated natriuresis after angiotensin AT1 receptor blockade or angiotensin- converting enzyme inhibition in obese Zucker rats.
Tallam LS; Jandhyala BS
Clin Exp Pharmacol Physiol; 2001; 28(5-6):433-40. PubMed ID: 11380518
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the renin angiotensin system decreases fibrogenic cytokine expression in tacrolimus nephrotoxicity in rats.
Deniz H; Oğütmen B; Cakalağaoğlu F; Tuğlular S; Ozener C; Akoğlu E
Transplant Proc; 2006 Mar; 38(2):483-6. PubMed ID: 16549154
[TBL] [Abstract][Full Text] [Related]
12. Reduced cardiac expression of plasminogen activator inhibitor 1 and transforming growth factor beta1 in obese Zucker rats by perindopril.
Toblli JE; Cao G; DeRosa G; Forcada P
Heart; 2005 Jan; 91(1):80-6. PubMed ID: 15604340
[TBL] [Abstract][Full Text] [Related]
13. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
14. Insulin resistance in two animal models of obesity: A comparison of HISS-dependent and HISS-independent insulin action in high-fat diet-fed and Zucker rats.
Afonso RA; Lautt WW; Ribeiro RT; Legare DJ; Macedo MP
Proc West Pharmacol Soc; 2007; 50():110-4. PubMed ID: 18605245
[TBL] [Abstract][Full Text] [Related]
15. [Effects of angiotensin II type 1 receptor blocker on triglyceride metabolism in the liver: experiment with Zucker fatty rats].
Ran JM; Lao GC; Xu G; Xie B; Zhang Y; Liu W; Feng Q; Guo J
Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(22):1557-61. PubMed ID: 18956640
[TBL] [Abstract][Full Text] [Related]
16. Hepatic-dependent and -independent insulin actions are impaired in the obese Zucker rat model.
Afonso RA; Ribeiro RT; Fernandes AB; Patarrão RS; Macedo MP
Obesity (Silver Spring); 2007 Feb; 15(2):314-21. PubMed ID: 17299103
[TBL] [Abstract][Full Text] [Related]
17. Effect of angiotensin-converting enzyme inhibition on skeletal muscle oxidative function and exercise capacity in streptozotocin-induced diabetic rats.
Rouyer O; Zoll J; Daussin F; Damgé C; Helms P; Talha S; Rasseneur L; Piquard F; Geny B
Exp Physiol; 2007 Nov; 92(6):1047-56. PubMed ID: 17675412
[TBL] [Abstract][Full Text] [Related]
18. Effects of aerobic exercise training on cardiac renin-angiotensin system in an obese Zucker rat strain.
Barretti DL; Magalhães Fde C; Fernandes T; do Carmo EC; Rosa KT; Irigoyen MC; Negrão CE; Oliveira EM
PLoS One; 2012; 7(10):e46114. PubMed ID: 23077501
[TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle capillary responses to insulin are abnormal in late-stage diabetes and are restored by angiotensin-converting enzyme inhibition.
Clerk LH; Vincent MA; Barrett EJ; Lankford MF; Lindner JR
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1804-9. PubMed ID: 17911341
[TBL] [Abstract][Full Text] [Related]
20. Attenuation of left ventricular dysfunction by an ACE inhibitor after myocardial infarction in a kininogen-deficient rat model.
Koch M; Bonaventura K; Spillmann F; Dendorfer A; Schultheiss HP; Tschöpe C
Biol Chem; 2008 Jun; 389(6):719-23. PubMed ID: 18627293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
